Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Disease Progression and STAT3[original query] |
|---|
| Pharmacogenomic and pharmacoproteomic studies of cetuximab in metastatic colorectal cancer: biomarker analysis of a phase I dose-escalation study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Mar 28 (7): 1181-9. Tabernero Josep, Cervantes Andres, Rivera Fernando, Martinelli Erika, Rojo Federico, von Heydebreck Anja, Macarulla Teresa, Rodriguez-Braun Edith, Eugenia Vega-Villegas Maria, Senger Stefanie, Ramos Francisco Javier, Roselló Susana, Celik Ilhan, Stroh Christopher, Baselga José, Ciardiello Fortuna |
| STAT3 genetic variant, alone and in combination with STAT5b polymorphism, contributes to breast cancer risk and clinical outcomes. Medical oncology (Northwood, London, England) 2015 Jan 32 (1): 375. Zhao Haishan, Wang Zhe, Wu Huizhe, Xiao Qinghuan, Yao Weifan, Wang Enhua, Liu Yong, Wei Minj |
| Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma. Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) 2022 9 74 127082. Chen Xueqin, Fu Guotao, Li Linglan, Zhao Qianqian, Ke Zunhua, Zhang Rongqia |
| Establishing the Molecular Diagnoses in a Cohort of 291 Patients With Predominantly Antibody Deficiency by Targeted Next-Generation Sequencing: Experience From a Monocentric Study. Frontiers in immunology 2022 1 12 786516. Rojas-Restrepo Jessica, Caballero-Oteyza Andrés, Huebscher Katrin, Haberstroh Hanna, Fliegauf Manfred, Keller Baerbel, Kobbe Robin, Warnatz Klaus, Ehl Stephan, Proietti Michele, Grimbacher Bo |
- Page last reviewed:Feb 1, 2024
- Content source: